All 152 XBI (SPDR(R) S&P(R) BIOTECH ETF) Holdings
There are 152 XBI holdings. Top 10 companies weight: 15.41%.
Total Market Cap: $1.54T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (152 stocks) | +11.38% | 28.98 | 15.04 | 0.45 | +35.29% | +12.59% | 0.70 | ||||||||||
101 | VIR | Vir Biotechnology Inc | 0.32% | $8.74 | $1.47B | Biotechnology | Healthcare | -0.01% | N/A | 4.27 | N/A | N/A | N/A | 82 | +135.24% | $21 | -28.26% | 1.58 |
102 | TYRA | Tyra Biosciences Inc | 0.30% | $28.66 | $1.97B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +78.47% | $51 | 0.00% | 1.05 |
103 | ANNX | Annexon Inc Ordinary Shares | 0.29% | $5.26 | $1.05B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +149.43% | $13 | -24.63% | 1.29 |
104 | GERN | Geron Corp | 0.29% | $1.17 | $843M | Biotechnology | Healthcare | -18.28% | N/A | N/A | N/A | N/A | N/A | 66 | +190.60% | $3.40 | -3.53% | 1.20 |
105 | RIGL | Rigel Pharmaceuticals Inc | 0.28% | $30.02 | $543M | Biotechnology | Healthcare | N/A | 4.92 | 6.63 | N/A | N/A | N/A | 65 | +77.22% | $53 | -4.61% | 1.16 |
106 | PURR | Hyperliquid Strategies Inc | 0.28% | $10.97 | $1.04B | Capital Markets | Financial Services | N/A | N/A | N/A | N/A | N/A | N/A | 83 | -12.67% | $9.58 | 0.00% | 3.37 |
107 | JANX | Janux Therapeutics Inc Ordinary Shares | 0.28% | $13.78 | $879M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +194.34% | $41 | 0.00% | 1.23 |
108 | SANA | Sana Biotechnology Inc Ordinary Shares | 0.28% | $3.24 | $826M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +164.51% | $8.57 | -31.19% | 2.04 |
109 | CGEM | Cullinan Therapeutics Inc | 0.27% | $15.34 | $954M | Biotechnology | Healthcare | N/A | N/A | 6.74 | N/A | N/A | N/A | 77 | +105.02% | $31 | -12.41% | 1.05 |
110 | AVBP | Arrivent Biopharma Inc | 0.26% | $29.92 | $1.24B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +40.71% | $42 | 0.00% | 0.94 |
111 | ORIC | Oric Pharmaceuticals Inc | 0.25% | $7.62 | $888M | Biotechnology | Healthcare | -10.25% | N/A | N/A | N/A | N/A | N/A | 76 | +167.19% | $20 | -17.85% | 1.45 |
112 | SVRA | Savara Inc | 0.25% | $5.25 | $1.07B | Biotechnology | Healthcare | -2.12% | N/A | 0.41 | N/A | N/A | N/A | 81 | +105.90% | $11 | +23.87% | 1.21 |
113 | SPRY | Ars Pharmaceuticals Inc | 0.24% | $8.90 | $844M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +223.60% | $29 | -21.09% | 1.20 |
114 | SION | Sionna Therapeutics Inc | 0.24% | $36.48 | $1.96B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +41.45% | $52 | 0.00% | 0.93 |
115 | ZBIO | Zenas Biopharma Inc | 0.23% | $17.13 | $1.13B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +145.88% | $42 | 0.00% | 1.30 |
116 | XNCR | Xencor Inc | 0.22% | $11.21 | $868M | Biotechnology | Healthcare | +10.21% | N/A | 68.03 | N/A | N/A | N/A | 76 | +154.24% | $29 | -21.07% | 1.50 |
117 | CTMX | Cytomx Therapeutics Inc | 0.22% | $3.16 | $675M | Biotechnology | Healthcare | N/A | 25.70 | 14.20 | 0.79 | N/A | N/A | 83 | +293.67% | $12 | -14.21% | 2.03 |
118 | BCAX | Bicara Therapeutics Inc | 0.21% | $19.64 | $1.41B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +60.18% | $31 | 0.00% | 1.44 |
119 | IRWD | Ironwood Pharmaceuticals Inc Class A | 0.21% | $3.28 | $611M | Drug Manufacturers - Specialty & Generic | Healthcare | -12.17% | 7.99 | 12.33 | N/A | N/A | N/A | N/A | +85.98% | $6.10 | -22.82% | 1.05 |
120 | EBS | Emergent Biosolutions Inc | 0.20% | $8.20 | $466M | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 2.08 | 0.38 | N/A | N/A | 75 | +46.34% | $12 | -33.20% | 2.02 |
121 | VOR | Vor Biopharma Inc Ordinary Shares | 0.18% | $13.66 | $841M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +177.31% | $38 | -49.05% | 1.21 |
122 | ALT | Altimmune Inc | 0.17% | $2.90 | $374M | Biotechnology | Healthcare | -10.93% | N/A | 8.18 | 32.62 | N/A | N/A | 75 | +453.79% | $16 | -25.83% | 1.55 |
123 | FDMT | 4d Molecular Therapeutics Inc Ordinary Shares | 0.16% | $9.27 | $463M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +204.42% | $28 | -19.55% | 1.33 |
124 | PRME | Prime Medicine Inc | 0.16% | $3.21 | $596M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 69 | +115.58% | $6.92 | 0.00% | 2.10 |
125 | VNDA | Vanda Pharmaceuticals Inc | 0.15% | $6.13 | $388M | Biotechnology | Healthcare | N/A | N/A | 103.09 | N/A | N/A | N/A | 70 | +143.07% | $15 | -19.38% | 0.64 |
126 | ALLO | Allogene Therapeutics Inc | 0.15% | $2.05 | $551M | Biotechnology | Healthcare | -14.18% | N/A | N/A | N/A | N/A | N/A | 76 | +307.32% | $8.35 | -38.90% | 1.53 |
127 | ABUS | Arbutus Biopharma Corp | 0.14% | $4.26 | $914M | Biotechnology | Healthcare | N/A | 5.69 | 10.25 | N/A | N/A | N/A | 83 | +20.66% | $5.14 | +7.63% | 0.91 |
128 | REPL | Replimune Group Inc | 0.14% | $8.87 | $374M | Biotechnology | Healthcare | +17.05% | N/A | N/A | N/A | N/A | N/A | 43 | -47.38% | $4.67 | -22.58% | 0.77 |
129 | PRTA | Prothena Corp Plc | 0.14% | $9.19 | $532M | Biotechnology | Healthcare | -1.54% | N/A | 10.63 | N/A | N/A | N/A | 62 | +132.86% | $21 | -20.36% | 0.92 |
130 | LXEO | Lexeo Therapeutics Inc | 0.13% | $4.51 | $377M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +356.76% | $21 | 0.00% | 2.00 |
131 | VSTM | Verastem Inc | 0.12% | $3.81 | $373M | Biotechnology | Healthcare | -2.77% | N/A | N/A | N/A | N/A | N/A | 77 | +319.95% | $16 | -39.57% | 1.45 |
132 | RGNX | Regenxbio Inc | 0.12% | $6.52 | $345M | Biotechnology | Healthcare | +13.05% | N/A | N/A | N/A | N/A | N/A | 81 | +270.86% | $24 | -28.40% | 1.76 |
133 | TRAX | First Tracks Biotherapeutics Inc | 0.12% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
134 | MYGN | Myriad Genetics Inc | 0.11% | $4.31 | $371M | Diagnostics & Research | Healthcare | N/A | N/A | 54.05 | N/A | N/A | N/A | 50 | +45.01% | $6.25 | -30.84% | 1.13 |
135 | CMPX | Compass Therapeutics Inc Ordinary Shares | 0.11% | $2.08 | $409M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +324.04% | $8.82 | -16.42% | 1.56 |
136 | MDXG | Mimedx Group Inc | 0.11% | $3.57 | $538M | Biotechnology | Healthcare | N/A | 17.38 | 19.53 | 2.88 | N/A | N/A | 79 | +82.07% | $6.50 | -19.16% | 0.76 |
137 | RCKT | Rocket Pharmaceuticals Inc | 0.11% | $2.89 | $326M | Biotechnology | Healthcare | -5.96% | N/A | N/A | N/A | N/A | N/A | 55 | +221.80% | $9.30 | -41.47% | 1.36 |
138 | AVXL | Anavex Life Sciences Corp | 0.10% | $2.79 | $256M | Biotechnology | Healthcare | +0.72% | N/A | 3.85 | N/A | N/A | N/A | 75 | +618.13% | $20 | -26.53% | 1.38 |
139 | OCGN | Ocugen Inc | 0.10% | $1.34 | $467M | Biotechnology | Healthcare | +8.79% | N/A | 13.07 | N/A | N/A | N/A | 78 | +752.99% | $11 | -31.51% | 1.75 |
140 | CATX | Perspective Therapeutics Inc | 0.10% | $3.58 | $475M | Medical Devices | Healthcare | +89.93% | N/A | 25.71 | N/A | N/A | N/A | 76 | +261.17% | $13 | -17.20% | 1.56 |
141 | AKBA | Akebia Therapeutics Inc | 0.09% | $0.94 | $276M | Drug Manufacturers - Specialty & Generic | Healthcare | -35.14% | N/A | 28.74 | N/A | N/A | N/A | 80 | +348.53% | $4.20 | -22.41% | 1.27 |
142 | n/a | Contra Metsera Inc Common Stock | 0.09% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
143 | IVVD | Invivyd Inc Ordinary Shares | 0.09% | $1.14 | $320M | Biotechnology | Healthcare | N/A | N/A | 44.64 | N/A | N/A | N/A | 75 | +777.19% | $10 | 0.00% | 1.35 |
144 | DMRA | Damora Therapeutics Inc Ordinary Shares | 0.03% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
145 | n/a | Ssi Us Gov Money Market Class State Street Inst Us Gov | 0.03% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
146 | n/a | Contra Akero Therapeut Common Stock | 0.02% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
147 | n/a | Contra Inhibrx Inc Common Stock | 0.01% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
148 | n/a | Contra Mirati Therapeu Common Stock | 0.01% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
149 | n/a | Contra Verve Therapeut Common Stock | 0.01% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
150 | n/a | Contra Blueprint Medic Common Stock | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
XBI (SPDR(R) S&P(R) BIOTECH ETF) Sector Allocation
HEALTHCARE
96.80%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%